Literature DB >> 3016498

Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.

J O Marcusson, I T Bäckström, S B Ross.   

Abstract

Recently, a high affinity [3H]imipramine-binding site of protein nature that appeared to be related to the 5-hydroxytryptamine (5-HT, serotonin) uptake mechanism was demonstrated. This binding site was only part of desipramine-displaceable [3H]imipramine binding, which contained a significant amount of additional binding not related to 5-HT uptake. The present study further investigates the [3H]imipramine-binding site of protein nature in the rat brain. Displacement by 5-HT and 6-methoxytetrahydro-beta-carboline (6-MeO-TH beta C) revealed monophasic displacement patterns with 60% displaceable binding. This binding fraction was abolished by protease treatment of the brain tissue prior to binding assay. Saturation studies of [3H]imipramine binding (1-30 nM) in rat cortex showed that the binding displaced by 30 microM 5-HT [Bmax 322 +/- 16 fmol/mg of protein, Kd 4.17 +/- 1.07 nM (means +/- SE)] was not different from the binding displaced by 1.0 microM norzimeldine (Bmax 349 +/- 15 fmol/mg of protein, Kd 4.47 +/- 1.07 nM) or 30 microM 6-MeO-TH beta C (Bmax 439 +/- 28 fmol/mg of protein, Kd 5.49 +/- 1.09 nM). When 100 microM desipramine was used in saturation studies, the binding was different from that displaced by 5-HT with Bmax 608 +/- 42 fmol/mg of protein and Kd 6.68 +/- 1.09 nM. Both displacement and saturation studies in which two displacing agents were combined indicated that most of the binding competed by 5-HT (30 microM) and norzimeldine (1.0 microM) is identical. Similarly, the binding displaced by 5-HT or norzimeldine is subsumed within 6-MeO-TH beta C (30 microM)-displaceable binding. Lesion studies with parachloroamphetamine, a selective toxin for 5-HT terminals, which resulted in a 83% reduction of [3H] 5-HT uptake ( [3H]noradrenaline uptake unaffected), abolished cortical [3H]imipramine binding displaced by 30 microM 5-HT or 1.0 microM norzimeldine. (greater than 80% reduction). However, with 100 microM desipramine as displacer, 40% of the binding remained in lesioned animals. The [3H]imipramine binding displaced by 30 microM 5-HT or 1.0 microM norzimeldine was sodium dependent, and an increase in NaCl concentration from 0 to 120 mM resulted in a 10-fold increase in affinity without effect on Bmax, whereas no change in binding was observed with increasing concentrations of LiCl.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016498

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain.

Authors:  J O Marcusson; A Andersson; I Bäckström
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Adrenergic, serotoninergic, histaminergic, and imipramine binding sites in post-mortal human cerebral microvessel preparations.

Authors:  C O'Neill; C J Fowler; J O Marcusson; B Winblad
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Unaltered 5-HT- and desipramine-sensitive [3H]imipramine binding and [3H]5-HT uptake in rat brain after chronic imipramine and norzimeldine treatment.

Authors:  J Marcusson; I T Bäckström; S B Ross
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Cerebral tryptophan hydroxylase activity, and 5-HT1A receptor, 5-HT2A receptor, and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats: relationships with behaviours in two models of anxiety.

Authors:  A Kulikov; N Castanon; P Mormède; F Chaouloff
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

5.  Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain.

Authors:  P Rosel; J M Menchon; M Oros; J Vallejo; T Cortadellas; B Arranz; P Alvarez; M A Navarro
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

6.  Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.

Authors:  Jacob Andersen; Olivier Taboureau; Kasper B Hansen; Lars Olsen; Jan Egebjerg; Kristian Strømgaard; Anders S Kristensen
Journal:  J Biol Chem       Date:  2009-02-12       Impact factor: 5.157

7.  Solubilization and characterization of [3H]imipramine and [3H]paroxetine binding sites from calf striatum.

Authors:  A Rotondo; G Giannaccini; C Quattrone; D Marazziti; C Martini; G B Cassano; A Lucacchini
Journal:  Neurochem Res       Date:  1994-10       Impact factor: 3.996

8.  The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.

Authors:  G Rudnick; S C Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  [3H]paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study.

Authors:  B Arranz; J Marcusson
Journal:  J Neural Transm Gen Sect       Date:  1994

10.  Effects of N-ethylmaleimide on 5-hydroxytryptamine transport and sodium content in rabbit platelets.

Authors:  R Wölfel; T Halbrügge; K H Graefe
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.